ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
의약품 재이용 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.3%로 성장할 전망이며, 534억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 비용 효과적인 치료법에 대한 수요 증가, 제약 기업의 투자 증가, 생명 공학 기업 간의 파트너십 확대, 종양학 및 신경학 용도 범위 확대 등으로 인한 것입니다. 예측 기간 동안 예상되는 주요 동향으로는 계산창약 툴의 진보, 의약품 재이용에 있어서 인공지능 및 머신러닝의 활용 강화, 약효 평가를 위한 예측 모델링 혁신, 약제 스크리닝 프로세스에 대한 빅데이터 분석의 통합, 바이오마커 동정에서의 진보 등을 들 수 있습니다.
신경퇴행성 질환의 유병률 증가는 향후 의약품 재사용 시장의 성장을 가속할 것으로 예측됩니다. 신경퇴행성 질환은 신경세포 사멸을 포함한 신경세포의 구조 및 기능의 진행성 상실을 특징으로 하는 질환군입니다. 알츠하이머형 치매와 같은 질병 증가는 평균 수명 증가로 인한 것이 크고, 노화는 여전히 시간이 지남에 따라 신경 세포 기능을 점차적으로 감소시키는 주요 위험 인자입니다. 의약품 재사용은 신경 퇴행성 질환의 치료에서 안전성 프로파일이 확립된 기존 약물을 확인하고 관련 질병 경로를 표적으로 삼아 효과적인 치료법 개발을 가속화하고 있습니다. 예를 들어, 2023년 3월 미국의 비영리자체건강단체인 알츠하이머병협회(Alzheimer's Association)는 65세 이상의 미국인 약 670만 명이 알츠하이머형 치매를 앓고 있다고 보고했으며, 2060년까지 1,380만 명으로 증가할 것으로 예측했습니다. 그 결과 신경퇴행성 질환의 유병률 상승이 의약품 재이용 시장 확대에 박차를 가하고 있습니다.
의약품 재이용 시장의 주요 기업은 인공지능(AI)을 활용한 약물-단백질 상호작용 모델링 등의 첨단 기술에 투자해 기존 약물의 새로운 치료 용도의 발견을 서두르고 있습니다. AI를 활용한 약물-단백질 상호작용 모델링은 인공지능과 머신러닝을 이용하여 약물이 인간 프로테옴 전체의 단백질과 어떻게 상호작용하는지를 예측하고 광범위한 데이터 세트를 활용하여 정확성 및 신뢰성을 향상시키고 있습니다. 예를 들어, 2025년 7월 미국의 헬스케어 기업인 Cosmos Health Inc.는 의약품 재사용을 위해 설계된 고급 AI 플랫폼인 Cloudscreen 2.0을 발표했습니다. 이 차세대 시스템은 전통적인 100배 이상의 데이터 세트를 처리하여 약물과 단백질 상호작용의 종합적인 분석을 가능하게 합니다. 돌연변이유발 데이터와 무질서 단백질을 분석하는 툴을 통합함으로써, 이 플랫폼은 암, 비만, 당뇨병 등의 질환을 대상으로 하고 있습니다. 또한 GPU 기반 클라우드 컴퓨팅은 확장 가능한 처리를 지원하며, 이 플랫폼은 여러 치료 영역에 걸쳐 연구개발 파이프라인을 가속화하는 중요한 혁신이 되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 의약품 재이용 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 의약품 재이용 시장 : 성장률 분석
세계의 의약품 재이용 시장 실적 : 규모 및 성장(2019-2024년)
세계의 의약품 재이용 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 의약품 재이용 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 의약품 재이용 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
질병 중심
대상 중심
약제 중심
세계의 의약품 재이용 시장 : 약제 분자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
생물제제
소분자
세계의 의약품 재이용 시장 : 치유 영역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양학
신경학
감염증
심혈관 질환
자가면역 질환
세계의 의약품 재이용 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
국소
흡입
근육내
세계의 의약품 재이용 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약회사
연구 및 학술기관
계약 연구 기관
세계의 의약품 재이용 시장 : 질환 중심 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
표현형 스크리닝
역학적 분석
임상 관찰에 의한 재이용
세계의 의약품 재이용 시장 : 대상 중심 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단백질 표적 조절
경로 조절
바이오마커에 의한 표적조절
세계의 의약품 재이용 시장 : 약제 중심 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
오프 대상 활동의 특정
구조에 의한 약물 재배치
유해 작용에 의한 재사용
제7장 지역별 및 국가별 분석
세계의 의약품 재이용 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 의약품 재이용 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
의약품 재이용 시장 : 경쟁 구도
의약품 재사용 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
International Business Machines Corporation(IBM) : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Amgen Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceutical Industries Limited
Astellas Pharma Inc.
UCB SA
Eisai Co Ltd.
Celltrion Inc.
Alnylam Pharmaceuticals Inc.
Evotec SE
BenevolentAI Limited
Insilico Medicine Inc.
Cosmos Health Inc.
Recursion Pharmaceuticals Inc.
Pharnext SA
Healx Ltd.
Algernon Pharmaceuticals Inc.
BioXcel Therapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
의약품 재이용 시장(2029년) : 새로운 기회를 제공하는 국가
의약품 재이용 시장(2029년) : 새로운 기회를 제공하는 부문
의약품 재이용 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Drug repurposing involves discovering new therapeutic applications for existing or previously unsuccessful drugs. This approach takes advantage of established safety data and pharmacological knowledge to shorten development timelines and reduce costs. The goal is to bring treatments to market more efficiently by skipping the initial stages of drug discovery.
The main approaches to drug repurposing include disease-centric, target-centric, and drug-centric strategies. Disease-centric repurposing involves focusing on a particular disease and evaluating a range of existing drugs to determine their potential efficacy, regardless of their original intended target. The drug types commonly involved are biologics and small molecules. Therapeutic areas include oncology, neurology, infectious diseases, cardiovascular conditions, and autoimmune disorders, with administration routes such as oral, intravenous, topical, inhalation, and intramuscular. These efforts serve various end users, including pharmaceutical companies, academic and research institutions, and contract research organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The drug repurposing market research report is one of a series of new reports from The Business Research Company that provides drug repurposing market statistics, including drug repurposing industry global market size, regional shares, competitors with a drug repurposing market share, drug repurposing market segments, market trends and opportunities, and any further data you may need to thrive in the drug repurposing industry. This drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The drug repurposing market size has grown strongly in recent years. It will grow from $34.12 billion in 2024 to $37.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the escalating costs of developing new drugs, a growing number of drug failures in clinical trials, increased demand for quicker drug approvals, greater availability of off-patent medications, and rising levels of government and academic research funding.
The drug repurposing market size is expected to see strong growth in the next few years. It will grow to $53.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be credited to the rising demand for cost-effective therapies, increased investments by pharmaceutical companies, growing partnerships among biotech firms, and the broadening scope of applications in oncology and neurology. Key trends anticipated during the forecast period include progress in computational drug discovery tools, enhanced utilization of artificial intelligence and machine learning in drug repurposing, innovations in predictive modeling for assessing drug efficacy, the integration of big data analytics into drug screening processes, and advancements in the identification of biomarkers.
The increasing prevalence of neurodegenerative diseases is expected to drive the growth of the drug repurposing market in the future. Neurodegenerative diseases are a group of disorders marked by the progressive loss of neuron structure or function, including neuronal death. The rise in conditions such as Alzheimer's dementia is largely due to increased life expectancy, as aging remains the primary risk factor contributing to the gradual decline of neuronal function over time. Drug repurposing aids in treating neurodegenerative diseases by identifying existing drugs with established safety profiles that can be redirected to target relevant disease pathways, thereby speeding up the development of effective therapies. For example, in March 2023, the Alzheimer's Association, a US-based nonprofit voluntary health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with projections estimating an increase to 13.8 million by 2060. Consequently, the rising prevalence of neurodegenerative diseases is fueling the expansion of the drug repurposing market.
Key companies in the drug repurposing market are investing in cutting-edge technologies such as artificial intelligence (AI)-powered drug-protein interaction modeling to hasten the discovery of new therapeutic applications for existing drugs. AI-powered drug-protein interaction modeling uses artificial intelligence and machine learning to predict how drugs interact with proteins across the human proteome, leveraging extensive datasets to improve accuracy and confidence. For instance, in July 2025, Cosmos Health Inc., a US-based healthcare company, launched Cloudscreen 2.0, an advanced AI platform designed for drug repurposing. This next-generation system processes datasets over 100 times larger than before, enabling comprehensive analysis of drug-protein interactions. By integrating mutagenesis data and tools to analyze disordered proteins, the platform targets diseases including cancer, obesity, and diabetes. Furthermore, GPU-based cloud computing supports scalable processing, making the platform a significant innovation for accelerating research and development pipelines across multiple therapeutic areas.
In July 2025, Predictive Oncology Inc., a US-based company specializing in AI-driven drug discovery and repurposing, partnered with YA II PN, Ltd., securing a $10 million share purchase agreement. Through this collaboration, Predictive Oncology aims to enhance its AI-driven platform to speed up the identification of new therapeutic uses for existing drugs and optimize oncology drug discovery processes. YA II PN, Ltd. is a US-based investment fund managed by Yorkville Advisors Global, LP, which provides financing to support such initiatives.
Major players in the drug repurposing market are F. Hoffmann-La Roche Ltd, International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co. Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., and BioXcel Therapeutics Inc.
North America was the largest region in the drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug repurposing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the drug repurposing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The drug repurposing market consists of revenues earned by entities by providing services such as computational drug screening, clinical trial design and support, regulatory consulting, bioinformatics analysis, and data mining of existing drug databases. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug repurposing market also includes sales of thalidomide, sildenafil, minoxidil, metformin, and azithromycin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Drug Repurposing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drug repurposing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drug repurposing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug repurposing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Disease-Centric; Target-Centric; Drug-Centric
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Drug Repurposing Market Characteristics
3. Drug Repurposing Market Trends And Strategies
4. Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Drug Repurposing Growth Analysis And Strategic Analysis Framework
5.1. Global Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Repurposing Market Growth Rate Analysis
5.4. Global Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Repurposing Total Addressable Market (TAM)
6. Drug Repurposing Market Segmentation
6.1. Global Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease-Centric
Target-Centric
Drug-Centric
6.2. Global Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Small Molecule
6.3. Global Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Infectious Diseases
Cardiovascular Diseases
Autoimmune Disorders
6.4. Global Drug Repurposing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Topical
Inhalation
Intramuscular
6.5. Global Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Research And Academic Institutes
Contract Research Organizations
6.6. Global Drug Repurposing Market, Sub-Segmentation Of Disease-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phenotypic Screening
Epidemiological Analysis
Clinical Observation-Based Repurposing
6.7. Global Drug Repurposing Market, Sub-Segmentation Of Target-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Target Modulation
Pathway Modulation
Biomarker-Based Targeting
6.8. Global Drug Repurposing Market, Sub-Segmentation Of Drug-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Off-Target Activity Identification
Structure-Based Drug Repositioning
Adverse Effect-Based Repurposing
7. Drug Repurposing Market Regional And Country Analysis
7.1. Global Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drug Repurposing Market
8.1. Asia-Pacific Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drug Repurposing Market
9.1. China Drug Repurposing Market Overview
9.2. China Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drug Repurposing Market
10.1. India Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drug Repurposing Market
11.1. Japan Drug Repurposing Market Overview
11.2. Japan Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drug Repurposing Market
12.1. Australia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drug Repurposing Market
13.1. Indonesia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drug Repurposing Market
14.1. South Korea Drug Repurposing Market Overview
14.2. South Korea Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drug Repurposing Market
15.1. Western Europe Drug Repurposing Market Overview
15.2. Western Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drug Repurposing Market
16.1. UK Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drug Repurposing Market
17.1. Germany Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drug Repurposing Market
18.1. France Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drug Repurposing Market
19.1. Italy Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drug Repurposing Market
20.1. Spain Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drug Repurposing Market
21.1. Eastern Europe Drug Repurposing Market Overview
21.2. Eastern Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drug Repurposing Market
22.1. Russia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drug Repurposing Market
23.1. North America Drug Repurposing Market Overview
23.2. North America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drug Repurposing Market
24.1. USA Drug Repurposing Market Overview
24.2. USA Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drug Repurposing Market
25.1. Canada Drug Repurposing Market Overview
25.2. Canada Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drug Repurposing Market
26.1. South America Drug Repurposing Market Overview
26.2. South America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drug Repurposing Market
27.1. Brazil Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drug Repurposing Market
28.1. Middle East Drug Repurposing Market Overview
28.2. Middle East Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drug Repurposing Market
29.1. Africa Drug Repurposing Market Overview
29.2. Africa Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drug Repurposing Market Competitive Landscape And Company Profiles
30.1. Drug Repurposing Market Competitive Landscape
30.2. Drug Repurposing Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Drug Repurposing Market Other Major And Innovative Companies
31.1. Teva Pharmaceutical Industries Limited
31.2. Astellas Pharma Inc.
31.3. UCB S.A.
31.4. Eisai Co Ltd.
31.5. Celltrion Inc.
31.6. Alnylam Pharmaceuticals Inc.
31.7. Evotec SE
31.8. BenevolentAI Limited
31.9. Insilico Medicine Inc.
31.10. Cosmos Health Inc.
31.11. Recursion Pharmaceuticals Inc.
31.12. Pharnext S.A.
31.13. Healx Ltd.
31.14. Algernon Pharmaceuticals Inc.
31.15. BioXcel Therapeutics Inc.
32. Global Drug Repurposing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Drug Repurposing Market
34. Recent Developments In The Drug Repurposing Market
35. Drug Repurposing Market High Potential Countries, Segments and Strategies
35.1 Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Repurposing Market In 2029 - Growth Strategies
